Zantac and its generic form ranitidine have been voluntarily recalled due to the presence of NDMA (N-Nitrosodimethylamine) which is a probable carcinogen. The FDA is alerting both patients and health care providers of these recalls while also conducting additional testing to determine the levels of NDMA.

Generic ranitidine, sold under the popular brand name Zantac, is one of the most widely used antacids in the United States. Zantac, which can be prescribed or obtained over-the-counter, is a histamine-2 blocker that decreases the amount of acid in a patient’s stomach. As an H2 blocker, it is generally used as a heartburn medication  associated with stomach acid indigestion. Zantac is also approved for the treatment and prevention of ulcers and gastroesophageal reflux disease.

What is NDMA?

NDMA is an organic chemical used in gasoline, rocket fuel, pesticides and fish processing as well as a lubricant additive and a stabilizer for industrial materials. In addition to Zantac and generic ranitidine medications, NDMA is also found in Valsartan and Losartan, two popular blood pressure medications. 

The FDA (U.S. Food and Drug Administration), EPA and World Health Organization have all classified NDMA as a carcinogen capable of causing cancer, and that NDMA exposure increases cancer risk. 

How was NDMA found in Zantac?

Valisure, an online pharmacy that conducted independent testing, found extremely high levels of NDMA, an active ingredient in Zantac, increasing the cancer risk for those prescribed with the antacid or take it over the counter. Based on their findings, Valisure filed a Citizen Petition calling on the FDA to seek a market recall due to the significant risks associated with NDMA. It has been reported that the levels of NDMA are 3,000 to 26,000 times higher than the FDA allowable limit.

Get a Free Case Evaluation

Lawyers Focused on Your Recovery

Thousands of Successful Cases in State and Federal Courts

Expertise in Dozens of Key Personal Injury Case Areas

Start Your Free Evaluation
Or Call
(866)735-2792

Get a Free Consultation With Our Zantac Mass Torts Lawyers

There are currently individual lawsuits and class action lawsuits filed against the manufacturer of Zantac alleging they intentionally concealed risks and knowingly manufactured and sold ranitidine products containing a probable carcinogen to millions of people.

If you were taking Zantac and developed cancer, our attorneys are available to discuss your potential claim. Lawsuits are often the only way for people to hold pharmaceutical companies accountable. The injury attorneys at Anapol Weiss will fight on your behalf for fair compensation. Call our office today for a free consultation.